Alzheimer's disease (AD) is marked by severe neurodegeneration and cognitive decline, presenting significant challenges for its prevention and treatment. Traditional hypotheses have focused on amyloid-beta plaques and Tau ...
Jul 25, 2024
0
0
Cyclophosphamide (CP), a widely used chemotherapeutic and immunosuppressive agent, has significant impacts on reproductive health in both males and females. A review published in the Journal of Exploratory Research in Pharmacology ...
Jul 23, 2024
0
0
A study, titled "Single-cell transcriptomic Atlas of aging macaque ocular outflow tissues" appearing in Protein & Cell, delves into the age-related changes in the trabecular meshwork (TM) of macaques, which are vital for ...
Jul 11, 2024
0
0
A new review paper was published in Aging titled "Peripheral vascular dysfunction and the aging brain."
Jun 12, 2024
0
0
A substance naturally occurring in pomegranates, strawberries and walnuts can improve memory and treatment of Alzheimer's disease, a new study conducted at the University of Copenhagen concludes.
May 22, 2024
0
21
The immune system strikes a fine balance by identifying and neutralizing disease-causing agents while carefully avoiding destruction of healthy tissues and cells. Now, researchers from Japan have shed new light on one of ...
May 20, 2024
0
6
A research paper published in the journal Cell Metabolism by the team of Prof. Liu Qiang at the University of Science and Technology of China (USTC) reveals the critical role of glutamate tRNA fragments in brain aging and ...
May 13, 2024
0
62
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues for cancer treatments that ...
May 3, 2024
0
0
During hepatic surgery or liver transplantation, the liver is vulnerable to ischemia-reperfusion injury (IRI), especially when vessels are compressed to control bleeding or during periods of ischemia. The hallmark of IRI ...
Apr 30, 2024
0
0
A team of researchers at Johannes Gutenberg University Mainz (JGU) has identified a mechanism that causes mitochondrial dysfunction in Alzheimer's patients resulting in a reduction of the supply of energy to the brain.
Apr 25, 2024
0
49
